Categories
Launch Matrubials

Launch HN: Matrubials (YC S21) Milk-derived therapeutics for infectious diesases

Hi, I’m Ishita, cofounder of Matrubials. We are developing milk-derived therapeutics to address infectious diseases.I have extensive experience in microbiology and infectious diseases in both academia and industry. Taken together, our founding team has ~100 years of combined experience in microbiology and ecology, food science and chemistry. My cofounders have previously founded other health companies…

Hi, I’m Ishita, cofounder of Matrubials. We are developing milk-derived therapeutics to address infectious diseases.

I have extensive experience in microbiology and infectious diseases in both academia and industry. Taken together, our founding team has ~100 years of combined experience in microbiology and ecology, food science and chemistry. My cofounders have previously founded other health companies with specialized products (eg. Evolve Biosystems and BCD Bioscience).

We have been focused on structure-function analysis of mammalian milk and the benefits individual components can bring to human health for about two decades. In recent years, we discovered peptides in milk that have selective antimicrobial activity, meaning that they know who the pathogens are, and essentially go after them fast for elimination while bypassing the “good” bugs, leaving them around to continue their jobs. That was the moment we decided we needed to bring these to the market.

One niche in the

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *